Search Spring Biosciences Products
Spring Bioscience was founded in 2001 by a team of scientists and achieved early success with their line of SP Clone rabbit monoclonal antibodies for clinical immunohistochemistry. This momentum was quickly noticed by Ventana Medical Systems who acquired the company in 2007 for its antibody development capabilities. Ventana Medical Systems was shortly thereafter acquired by Roche. Today Spring serves an important role as an antibody center of excellence in Roche’s mission to deliver companion diagnostics. This is accomplished through not only developing antibodies destined for clinical assays through Ventana and other Roche affiliates but using our collective medical/market intelligence to serve the cancer research community.
Still Need More Help?
If you have sales questions relative to particular products or to your line of research,
please contact the CEDARLANE® sales department and have all of your questions answered
in a timely and professional manner.